Status:

COMPLETED

Use of Probiotics as Adjunctive Treatment for Chronic Rhinosinusitis

Lead Sponsor:

University of Michigan

Collaborating Sponsors:

Institut Rosell

Conditions:

Chronic Rhinosinusitis

Eligibility:

All Genders

15-70 years

Phase:

PHASE4

Brief Summary

Chronic sinusitis is reported to be one of the most widespread disorders in the United States. It can be caused by a variety of reasons such as allergy, infection and/or defects in T-cells which help ...

Detailed Description

Probiotics are live microorganisms which when administered in adequate amounts confer a health benefit on the host. They are a part of the normal gastrointestinal flora and have safely been used to bo...

Eligibility Criteria

Inclusion

  • Age ≥15 and ≤70 years.
  • The patient must be bothered by each of the two following symptoms(\>50% of days in the last 3 months):
  • A. More than 12 consecutive weeks of symptomatic nasal obstruction and, B. More than 12 weeks of symptomatic nasal discharge.
  • An Otolaryngologist evaluation and diagnosis of chronic inflammatory rhinosinusitis (hyperplastic mucosa, polyps in absence of overt bacterial infection)
  • Access to telephone (home or person cell).

Exclusion

  • Sinus surgery within the last 3 months
  • Acute illness within the last 2 weeks requiring antibiotics: including: otitis media, pharyngitis, bronchitis, or laryngitis.
  • Immunosuppression (due to medications including oral steroids, or due to autoimmune diseases, HIV infection, cystic fibrosis, immunodeficiency, malignancies, uncontrolled diabetes mellitus, chronic renal failure, etc.)
  • Patients with chronic or acute bacterial sinusitis.(Clinical diagnosis-to be decided by MD)
  • An allergic reaction to a probiotic dietary supplement in the past (such as symptoms of tightness in the chest, breathing difficulties, skin hives, rash or other clinical symptoms consistent with sensitivity or intolerance)
  • Inability to speak or read English.
  • Pregnancy and Lactation

Key Trial Info

Start Date :

November 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2008

Estimated Enrollment :

77 Patients enrolled

Trial Details

Trial ID

NCT00396162

Start Date

November 1 2006

End Date

February 1 2008

Last Update

September 20 2016

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.